Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation

Human Immunology

Volumn 74, Issue 3, 2013, Pages 290-296

  Otten, Henny G ^a   Calis, Jorg J A ^b   Keşmir, Can ^b   van Zuilen, Arjan D ^a   Spierings, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CELL COUNT; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANTIBODIES; COMPUTER SIMULATION; EPITOPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; TISSUE DONORS;

EID: 84873719493     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.004     Document Type: Article

References (23)

1. Opelz G., Wujciak T., Dohler B., Scherer S., Mytilineos J. HLA compatibility and organ transplant survival. Collaborative transplant study. Rev Immunogenet 1999, 1:334-342.
2. Terasaki P.I., Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008, 86:377-383.
3. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002, 63:339-352.
4. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67:847-862.
5. Duquesnoy R.J. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications. Tissue Antigens 2011, 77:525-534.
6. Claas F.H. Predictive parameters for in vivo alloreactivity. Transpl Immunol 2002, 10:137-142.
7. Lanzavecchia A, Bove S. Specific B lymphocytes efficiently pick up, process and present antigen to T cells. Behring Inst Mitt ;1985. p. 82-7.
8. Roosnek E., Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991, 173:487-489.
9. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., Van K.C., et al. The CD40 antigen and its ligand. Ann Rev Immunol 1994, 12:881-922.
10. Fuller T.C., Fuller A. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder. Transplantation 1999, 68:173-182.
11. Dankers M.K., Roelen D.L., Nagelkerke N.J., De L.P., Persijn G.G., Doxiadis I.I., et al. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens. Hum Immunol 2004, 65:13-19.
12. Papassavas A.C., Barnardo M.C., Bunce M., Welsh K.I. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?. Transplantation 2002, 73:642-651.
13. Suciu-Foca N., Liu Z., Harris P.E., Reed E.F., Cohen D.J., Benstein J.A., et al. Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc 1995, 27:455-456.
14. Peters B., Bui H.H., Frankild S., Nielson M., Lundegaard C., Kostem E., et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2006, 2:e65.
15. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
16. Nielsen M., Lund O., Buus S., Lundegaard C. MHC class II epitope predictive algorithms. Immunology 2010, 130:319-328.
17. Nielsen M., Lundegaard C., Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007, 8:238.
18. Nielsen M., Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009, 10:296.
19. Maiers M., Gragert L., Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007, 68:779-788.
20. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 1998, 160:3363-3373.
21. Duquesnoy R.J., Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009, 74:117-133.
22. Billen E.V., Christiaans M.H., Lee J., van den Berg-Loonen E.M. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay. Transplantation 2009, 87:563-569.
23. Nielsen M., Justesen S., Lund O., Lundegaard C., Buus S. NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res 2010, 6:9.